Thank you to Mission BioCapital, Eli Lilly, and Ono Venture Investments for this incredible recognition! We are excited to have your support as we continue our mission to target under-drugged human enzymes!
Supporting early stage biotech is in our DNA! We've invested in 8 innovative young companies through the 2022 and 2023 Platinum Program and together with our pharma, services, and lab partners around the world we are collectively supporting their launch and growth. Learn more about our growing portfolio of Platinum Ticket investments. And stay tuned for the 2025 Platinum Program launch in the new year! Alloy Therapeutics, Inc., Goodwin, van den Boom & Associates LLC Eli Lilly and Company, Ono Venture Investment